The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 03, 2023

Filed:

Jan. 31, 2017
Applicant:

Theradep Technologies, Inc., Palo Alto, CA (US);

Inventors:

Apoorva Shah, Burlington, MA (US);

Liam O'Neill, Midleton, IE;

Patrick Burt, Palo Alto, CA (US);

John O'Donoghue, County Waterford, IE;

Assignee:

THERADEP TECHNOLOGIES INC., Palo Alto, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
B05D 1/00 (2006.01); A61B 18/04 (2006.01); A61L 27/28 (2006.01); A61L 27/54 (2006.01); A61L 29/08 (2006.01); A61L 29/16 (2006.01); A61L 31/08 (2006.01); A61L 31/16 (2006.01); A61N 1/44 (2006.01); B01L 3/00 (2006.01); B05D 3/02 (2006.01); B05D 3/14 (2006.01); B05D 7/00 (2006.01); A61B 18/00 (2006.01);
U.S. Cl.
CPC ...
B05D 1/62 (2013.01); A61B 18/042 (2013.01); A61L 27/28 (2013.01); A61L 27/54 (2013.01); A61L 29/08 (2013.01); A61L 29/16 (2013.01); A61L 31/08 (2013.01); A61L 31/16 (2013.01); A61N 1/44 (2013.01); B01L 3/5085 (2013.01); B05D 3/0254 (2013.01); B05D 3/145 (2013.01); B05D 7/54 (2013.01); A61B 2018/00589 (2013.01); A61L 2420/02 (2013.01); B01L 2200/12 (2013.01);
Abstract

Plasma systems for depositing biomolecules, pharmaceutical agents, and other therapeutic active agents onto surfaces are described. The systems may include a plasma device having one or more electrodes, a gas supply inlet, a plasma outlet exposed to ambient pressure, and an ignition system operatively connected to the electrodes for providing a non-thermal equilibrium plasma within the plasma chamber. A particulate delivery system may be used to introduce the active agent(s) as a dry powder into or downstream of the plasma, and to deposit the plasma-treated active agent(s) to produce a coating on a surface. The coating may retain the activity of the active agent(s).


Find Patent Forward Citations

Loading…